Fundraising Fox

Veradermics

NYSE: MANE

West Hartford, US · Founded 2021 · Delaware corporation · 7 known investors

Find your way into Veradermics

286 people in our graph share verified history with the Veradermics team — schools, employers, funds. One of them is your warm intro.

Deborah Leeunlockedknows Reid Waldman · together at Cedars-Sinai (overlapped)
×7knows the team · via United States Air Force
knows the team · via Piction Health
×2knows the team · via University of Notre Dame
knows the team · via Loyola University Chicago Stritch School of Medicine

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men. The therapy is being evaluated in Phase 2 and Phase 3 clinical trials.

BiotechHealthtech

Founders & leadership

Veradermics was founded in 2021 by Reid Waldman.

RWReid Waldman
Reid WaldmaninFounderReid Waldman is a board-certified dermatologist who founded Veradermics to develop improved treatments for pattern hair loss. He completed a BA/MD through the University of Missouri–Kansas City and a dermatology residency at the University of Connecticut, and has authored over 100 peer-reviewed publications in dermatology.30 Under 30 2024
TDTim Durso
Tim DursoinChief Technical OfficerTim Durso is a board-certified dermatologist with over 10 years of clinical experience who co-founded Veradermics with Reid Waldman. As Chief Technical Officer, he leads research and development for the company's pipeline including VDPHL01, an oral minoxidil therapeutic in Phase 3 clinical trials for pattern hair loss.
DCDominic Carrano
Dominic CarranoinChief Financial Officer and Treasurer
MNMark Neumann
Mark NeumannChief Commercial and Strategy Officer
JW
John W. ChildsNamed on SEC filing
JG
Jane Grant-KelsNamed on SEC filing
VC
Vladimir CoricNamed on SEC filing

Investors · 7

Longitude Capital✓ verifiedMenlo Park · $10M – $30M
Connecticut InnovationsNew Haven · $500K – $2M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
SR One Capital ManagementRedwood City
abrdn plcreportedEdinburgh
InvusreportedNew York
LifeSci Venture PartnersreportedNew York

Reported raises · per SEC filings

Form D private placements

$269.3M disclosed across 6 rounds · 2020–2026

▶$30MraisedMay 2026 · 2 investors · Other Health Care
Rule 506(b)
Veradermics Tumbles as Lock-Up Expiry Spooks Investors - TipRanks.comtipranks.com · Aug 2026Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, toofiercepharma.com · Jul 2026
Officers, directors & promoters on the filing
  • PATRICK ENRIGHTDirector
  • DAVID FRIEDMANDirector
  • JOHN CHILDSDirector
  • JANE GRANT-KELSDirector
  • VLADIMIR CORICDirector
  • MICHAEL GRECOExecutive Officer
  • REID WALDMANExecutive Officer, Director
  • KATARINA PANCEDirector
  • MARK NEUMANNExecutive Officer
  • DOMINIC CARRANOExecutive Officer
  • TIM DURSOExecutive Officer
Offering amount
$30M
Amount sold
$30M
Sales commissions
$1.8M
Placement agents
JEFFERIES LLC, LEERINK PARTNERS LLC, CITIGROUP GLOBAL MARKETS INC., CANTOR FITZGERALD & CO., LIFESCI CAPITAL, NEEDHAM & COMPANY, LLC
First sale
May 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$135MraisedOct 2025 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick EnrightDirector
  • Katarina PanceDirector
  • Amanda Birdsey-BensonDirector
  • John ChildsDirector
  • Vladimir CoricDirector
  • Jane Grant-KelsDirector
  • Reid WaldmanExecutive Officer, Director
Offering amount
$150M
Amount sold
$135M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$66.6MraisedDec 2024 · 40 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jane Grant-KelsDirector
  • Reid WaldmanExecutive Officer, Director
  • Amanda Birdsey-BensonDirector
  • Christopher EklundDirector
  • Vladimir CoricDirector
  • Patrick EnrightDirector
  • John W. ChildsDirector
Offering amount
$75M
Amount sold
$66.6M
First sale
Nov 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMay 2023 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John W. ChildsDirector
  • Reid WaldmanExecutive Officer, Director
  • Jane Grant-KelsDirector
  • Vladimir CoricDirector
  • Timothy DursoExecutive Officer, Director
Offering amount
$15M
Amount sold
$15M
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.2MraisedOct 2021 · 41 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Vladimir CoricDirector
  • Reid WaldmanExecutive Officer, Director
  • Jane Grant-KelsDirector
  • John W. ChildsDirector
  • Timothy DursoExecutive Officer, Director
Offering amount
$22.2M
Amount sold
$22.2M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$476.1KraisedOct 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy DursoExecutive Officer, Director
  • Reid WaldmanExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$476.1K
First sale
Sep 2020
Incorporated
Corporation, Texas, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Allure51 shared keywordsAllure is a beauty journalism publication that provides product reviews, trend reporting, and expert guidance on makeup, hair, skincare, and wellness. The publication serves beauty consumers and industry professionals through its website, social channels, and subscription service.
Hims & Hers45 shared keywordsUS direct-to-consumer telehealth company selling prescription and OTC treatments online by subscription; NYSE-listed as HIMS.
Ro29 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.

Companies competing with Veradermics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Veradermics, Incorporated (MANE) Presents at Citigroup's Biopharma Back to School Summit 2026 Prepared Remarks Transcript | Seeking Alphaseekingalpha.com · Sep 2026Veradermics to Present at Upcoming September 2026 Investor Conferences - BioSpacebiospace.com · Sep 2026Veradermics Raises $256 Million in Upsized Initial Public Offering | PharmExecpharmexec.com · Aug 2026Veradermics Tumbles as Lock-Up Expiry Spooks Investors - TipRanks.comtipranks.com · Aug 2026MANE Stock Draws Traders As Volatility And Cash Pile Stand Out - StocksToTradestockstotrade.com · Jul 2026B.Riley initiates Veradermics stock coverage with Buy on hair loss drug By Investing.cominvesting.com · Jul 2026Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, toofiercepharma.com · Jul 2026Hair Loss Biopharma Firm Veradermics Raises $256 Million in IPO - Bloombergbloomberg.com · Feb 2026

Frequently asked questions

What does Veradermics do?
Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men. The therapy is being evaluated in Phase 2 and Phase 3 clinical trials.
Who founded Veradermics?
Veradermics was founded by Reid Waldman in 2021.
Who are Veradermics's investors?
Veradermics's investors include Longitude Capital, Connecticut Innovations, OUP (Osage University Partners), SR One Capital Management, abrdn plc, Invus, LifeSci Venture Partners.
How much funding has Veradermics raised?
Veradermics has disclosed $269.3M raised across 6 rounds.
Where is Veradermics headquartered?
Veradermics is headquartered in West Hartford, US.